SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Boehringer Ingelheim and SBP Group Enter Cancer-Therapy Partnership

The partnership is intended to advance next-generation cancer therapies. The available report says it provides opportunities to expand Boehringer Ingelheim’s antibody-drug conjugate portfolio.

Related stories